Decidual cell regulation of hemostasis during implantation and menstruation.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing in vitro cell culture models and mechanistic data
PubMed 9329839 · doi:10.1111/j.1749-6632.1997.tb48539.x
What was done
This narrative review synthesizes experimental findings from an in vitro model of human endometrial stromal cell decidualization. Cultured stromal cell monolayers derived from predecidualized human endometrium were treated with estradiol, progestins, or subjected to steroid withdrawal to evaluate the expression of proteins involved in hemostasis, extracellular matrix degradation, and vasoactive regulation.
What was found
The abstract reports no numerical values, effect sizes, or statistical metrics. Qualitatively, progestin exposure (enhanced by estradiol priming) induced decidualization and markedly increased the expression of stromal tissue factor (TF) and plasminogen activator inhibitor-1 (PAI-1), accompanied by reciprocal inhibition of tissue plasminogen activator (tPA) activity. Steroid withdrawal in decidualized cells reversed these expression profiles, converting the environment into a hemorrhage-promoting state.
Why it matters
This work provides a mechanistic framework explaining how ovarian steroid fluctuations allow endometrial stromal cells to prevent hemorrhage during trophoblast invasion in pregnancy while permitting necessary bleeding during menstruation.
Limits
The findings rely primarily on in vitro monolayer cell cultures, which lack the tissue architecture, immune components, and hemodynamics of intact human endometrium. The abstract provides no quantitative data, sample sizes, or patient baseline characteristics.
Cited by
- supports In the days leading up to menstruation, a sharp drop in estrogen and progesterone cuts off blood supply to the endometrial lining, causing tissue ischemia and subsequent shedding.